Comprehensive analysis of differentially expressed microRNAs and mRNAs involved in diabetic corneal neuropathy

Yuan Zhang,Hui Jiang,Shengqian Dou,Bin Zhang,Xia Qi,Jing Li,Qingjun Zhou,Weina Li,Chen Chen,Qun Wang,Lixin Xie
DOI: https://doi.org/10.1016/j.lfs.2020.118456
IF: 6.78
2020-11-01
Life Sciences
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Aims</h3><p>Corneal nerve fibers are derived from the ophthalmic division of the trigeminal ganglion (TG). Here, by sequencing of microRNAs (miRNAs) and messenger RNAs (mRNAs) from diabetic and normal TG tissues, we aimed to uncover potential miRNAs, mRNAs, and the network of their interactions involved in the pathogenesis of diabetic corneal neuropathy.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Main methods</h3><p>We performed RNA sequencing to systematically screen out differentially expressed miRNAs and mRNAs in TG tissues from diabetic and normal mice. Functional enrichment analyses were performed to illustrate the biological functions of differentially expressed mRNAs (DEmRNAs). Following this, miRNA-mRNA regulatory networks were built by means of bioinformatics methods to suggest regulatory role for miRNAs in the pathogenesis of diabetic corneal neuropathy. Finally, the credibility of the sequencing-based results was validated using qRT-PCR.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Key findings</h3><p>Sequencing analyses disclosed that 68 miRNAs and 114 mRNAs were differentially expressed in diabetic TG tissues compared with normal TG samples. The functional analyses showed that DEmRNAs participated in diabetes-related biological processes. After applying an optimized approach to predict miRNA–mRNA pairs, a miRNA-mRNA interacting network was inferred. Subsequently, the expression and correlation of miR-350-5p and <em>Mup20</em>, miR-592-5p and <em>Angptl7</em> as well as miR-351-5p and <em>Elovl6</em> were preliminarily validated.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Significance</h3><p>Our study provides a systematic characterization of miRNA and mRNA expression in the TG during diabetic corneal neuropathy and will contribute to the development of clinical diagnostic and therapeutic strategies for diabetic corneal neuropathy.</p>
pharmacology & pharmacy,medicine, research & experimental
What problem does this paper attempt to address?
The problem that this paper attempts to solve is the pathogenesis of diabetic corneal neuropathy. Specifically, by comparing the expression differences of microRNAs (miRNAs) and messenger RNAs (mRNAs) in the trigeminal ganglion (TG) tissues of diabetic mice and normal mice, the researchers aim to reveal the potential miRNAs, mRNAs and their interaction networks involved in the occurrence and development of diabetic corneal neuropathy. This research not only helps to understand the molecular mechanism of diabetic corneal neuropathy, but also may provide new targets for the development of clinical diagnosis and treatment strategies. The main methods of the research include: - Using RNA sequencing technology to systematically screen for differentially expressed miRNAs and mRNAs in TG tissues of diabetic and normal mice. - Conducting functional enrichment analysis to illustrate the biological functions of differentially expressed mRNAs (DEmRNAs). - Using bioinformatics methods to construct miRNA - mRNA regulatory networks to indicate the regulatory role of miRNAs in the pathogenesis of diabetic corneal neuropathy. - Finally, using quantitative real - time polymerase chain reaction (qRT - PCR) to verify the reliability of the sequencing - based results. Through these methods, the researchers hope to comprehensively characterize the expression of miRNA and mRNA in TG during the process of diabetic corneal neuropathy and provide a theoretical basis for further development of clinical diagnosis and treatment strategies.